Myocardial Infarction Ontology

Last uploaded: February 21, 2023
Preferred Name

fenofibrate

Synonyms

lofibra

tricor

Definitions

A synthetic phenoxy-isobutyric acid derivate and prodrug with antihyperlipidemic activity. Fenofibrate is hydrolyzed in vivo to its active metabolite fenofibric acid that binds to and activates peroxisome proliferator activated receptor alpha (PPARalpha), resulting in the activation of lipoprotein lipase and reduction of the production of apoprotein C-III, an inhibitor of lipoprotein lipase activity. Increased lipolysis and a fall in plasma triglycerides, in turn, leads to the modification of the small, dense low density lipoporotein (LDL) particles into larger particles that are catabolized more rapidly due to a greater affinity for cholesterol receptors. In addition, activation of PPARalpha also increases the synthesis of apoproteins A-I, A-II, and high density lipoprotein (HDL)-cholesterol. Overall, fenofibrate reduces total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) while increasing HDL cholesterol. [url:http://purl.obolibrary.org/obo/NCIT_C29047]

ID

http://www.semanticweb.org/admin/ontologies/2022/7/MIO:02185

definition

A synthetic phenoxy-isobutyric acid derivate and prodrug with antihyperlipidemic activity. Fenofibrate is hydrolyzed in vivo to its active metabolite fenofibric acid that binds to and activates peroxisome proliferator activated receptor alpha (PPARalpha), resulting in the activation of lipoprotein lipase and reduction of the production of apoprotein C-III, an inhibitor of lipoprotein lipase activity. Increased lipolysis and a fall in plasma triglycerides, in turn, leads to the modification of the small, dense low density lipoporotein (LDL) particles into larger particles that are catabolized more rapidly due to a greater affinity for cholesterol receptors. In addition, activation of PPARalpha also increases the synthesis of apoproteins A-I, A-II, and high density lipoprotein (HDL)-cholesterol. Overall, fenofibrate reduces total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) while increasing HDL cholesterol. [url:http://purl.obolibrary.org/obo/NCIT_C29047]

label

fenofibrate

MIO_ID

MIO:02185

prefLabel

fenofibrate

reference

NCIT:C29047

synonyms

lofibra

tricor

subClassOf

http://www.semanticweb.org/admin/ontologies/2022/7/MIO:01111

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/CHEBI_5001 GO-PLUS LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 EFO LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 OBA LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 HOIP LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 CHEBI LOOM
http://purl.obolibrary.org/obo/XCO_0000679 XCO LOOM
http://purl.obolibrary.org/obo/OMIT_0012301 OMIT LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 CCONT LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 HSPO LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 COVID-19 LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 TXPO LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 BIOMODELS LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_5001 NIFSTD LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D02.455.426.559.389.115.124.750 RH-MESH LOOM
http://purl.bioontology.org/ontology/LNC/LP171398-3 LOINC LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D02.455.426.559.389.657.654.305.625 RH-MESH LOOM
http://purl.bioontology.org/ontology/RCD/bxc.. RCD LOOM
http://purl.bioontology.org/ontology/MESH/D011345 MESH LOOM
http://purl.jp/bio/4/id/200906089354123549 IOBC LOOM
http://www.drugbank.ca/drugs/DB01039 FTC LOOM
http://purl.bioontology.org/ontology/VANDF/4021098 VANDF LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/386879008 SNOMEDCT LOOM
http://purl.obolibrary.org/obo/NCIT_C29047 BERO LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#10140 OCHV LOOM
http://stirdf.jst.go.jp/id/200907014115340493 IOBC LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C29047 NCIT LOOM
http://www.co-ode.org/ontologies/galen#Fenofibrate GALEN LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D02.355.726.305.625 RH-MESH LOOM
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000148554 OCVDAE LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000148554 NDFRT LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D011345 RH-MESH LOOM
http://purl.obolibrary.org/obo/MESH_D011345 BERO LOOM
http://purl.bioontology.org/ontology/ATC/C10AB05 ATC LOOM
http://purl.bioontology.org/ontology/NDDF/003789 NDDF LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D02.522.223.750 RH-MESH LOOM
http://www.phoc.org.cn/pmo/class/PMO_00016328 PMAPP-PMO LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D02.241.081.114.968.500.625 RH-MESH LOOM
https://go.drugbank.com/drugs/DB01039 MDM LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0033228 OCHV LOOM
http://purl.bioontology.org/ontology/RXNORM/8703 RXNORM LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000459750 PDQ LOOM